Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV013919296 | ||
| 003 | DE-604 | ||
| 007 | t | ||
| 008 | 010919s2001 d||| |||| 10||| ger d | ||
| 016 | 7 | |a 962262587 |2 DE-101 | |
| 020 | |a 3805572875 |9 3-8055-7287-5 | ||
| 035 | |a (OCoLC)48727874 | ||
| 035 | |a (DE-599)BVBBV013919296 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-19 | ||
| 245 | 1 | 0 | |a Oxaliplatin (Eloxatin) |b Fortschritte in der Tumortherapie 2001 |c Gast-Hrsg.: H.-J. Schmoll |
| 264 | 1 | |a Basel [u.a.] |b Karger |c 2001 | |
| 300 | |a VI, 41 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Onkologie |v 24, Suppl. 4 | |
| 650 | 7 | |a Kongress |2 gtt | |
| 650 | 7 | |a Krebs <Medizin> |2 gtt | |
| 650 | 7 | |a Oxaliplatin |2 gtt | |
| 650 | 7 | |a Therapie |2 gtt | |
| 650 | 0 | 7 | |a Oxaliplatin |0 (DE-588)4687339-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Oxaliplatin |0 (DE-588)4687339-9 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Schmoll, Hans-Joachim |d 1946- |e Sonstige |0 (DE-588)106820664 |4 oth | |
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1805078266456834048 |
|---|---|
| adam_text | |
| any_adam_object | |
| author_GND | (DE-588)106820664 |
| building | Verbundindex |
| bvnumber | BV013919296 |
| ctrlnum | (OCoLC)48727874 (DE-599)BVBBV013919296 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV013919296</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">010919s2001 d||| |||| 10||| ger d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">962262587</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805572875</subfield><subfield code="9">3-8055-7287-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)48727874</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013919296</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Oxaliplatin (Eloxatin)</subfield><subfield code="b">Fortschritte in der Tumortherapie 2001</subfield><subfield code="c">Gast-Hrsg.: H.-J. Schmoll</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VI, 41 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Onkologie</subfield><subfield code="v">24, Suppl. 4</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kongress</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Krebs <Medizin></subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oxaliplatin</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Therapie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Oxaliplatin</subfield><subfield code="0">(DE-588)4687339-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Oxaliplatin</subfield><subfield code="0">(DE-588)4687339-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmoll, Hans-Joachim</subfield><subfield code="d">1946-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)106820664</subfield><subfield code="4">oth</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV013919296 |
| illustrated | Illustrated |
| indexdate | 2024-07-20T06:26:21Z |
| institution | BVB |
| isbn | 3805572875 |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009523788 |
| oclc_num | 48727874 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | VI, 41 S. graph. Darst. |
| publishDate | 2001 |
| publishDateSearch | 2001 |
| publishDateSort | 2001 |
| publisher | Karger |
| record_format | marc |
| series2 | Onkologie |
| spelling | Oxaliplatin (Eloxatin) Fortschritte in der Tumortherapie 2001 Gast-Hrsg.: H.-J. Schmoll Basel [u.a.] Karger 2001 VI, 41 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Onkologie 24, Suppl. 4 Kongress gtt Krebs <Medizin> gtt Oxaliplatin gtt Therapie gtt Oxaliplatin (DE-588)4687339-9 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Oxaliplatin (DE-588)4687339-9 s 1\p DE-604 Schmoll, Hans-Joachim 1946- Sonstige (DE-588)106820664 oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Oxaliplatin (Eloxatin) Fortschritte in der Tumortherapie 2001 Kongress gtt Krebs <Medizin> gtt Oxaliplatin gtt Therapie gtt Oxaliplatin (DE-588)4687339-9 gnd |
| subject_GND | (DE-588)4687339-9 (DE-588)1071861417 |
| title | Oxaliplatin (Eloxatin) Fortschritte in der Tumortherapie 2001 |
| title_auth | Oxaliplatin (Eloxatin) Fortschritte in der Tumortherapie 2001 |
| title_exact_search | Oxaliplatin (Eloxatin) Fortschritte in der Tumortherapie 2001 |
| title_full | Oxaliplatin (Eloxatin) Fortschritte in der Tumortherapie 2001 Gast-Hrsg.: H.-J. Schmoll |
| title_fullStr | Oxaliplatin (Eloxatin) Fortschritte in der Tumortherapie 2001 Gast-Hrsg.: H.-J. Schmoll |
| title_full_unstemmed | Oxaliplatin (Eloxatin) Fortschritte in der Tumortherapie 2001 Gast-Hrsg.: H.-J. Schmoll |
| title_short | Oxaliplatin (Eloxatin) |
| title_sort | oxaliplatin eloxatin fortschritte in der tumortherapie 2001 |
| title_sub | Fortschritte in der Tumortherapie 2001 |
| topic | Kongress gtt Krebs <Medizin> gtt Oxaliplatin gtt Therapie gtt Oxaliplatin (DE-588)4687339-9 gnd |
| topic_facet | Kongress Krebs <Medizin> Oxaliplatin Therapie Konferenzschrift |
| work_keys_str_mv | AT schmollhansjoachim oxaliplatineloxatinfortschritteindertumortherapie2001 |